Your browser doesn't support javascript.
loading
Role of epigenetics and alterations in RNA metabolism in leukodystrophies.
Rey, Federica; Esposito, Letizia; Maghraby, Erika; Mauri, Alessia; Berardo, Clarissa; Bonaventura, Eleonora; Tonduti, Davide; Carelli, Stephana; Cereda, Cristina.
Afiliación
  • Rey F; Pediatric Clinical Research Center "Romeo ed Enrica Invernizzi," Department of Biomedical and Clinical Sciences, University of Milano, Milan, Italy.
  • Esposito L; Center of Functional Genomics and Rare Diseases, Department of Pediatrics, Buzzi Children's Hospital, Milan, Italy.
  • Maghraby E; Pediatric Clinical Research Center "Romeo ed Enrica Invernizzi," Department of Biomedical and Clinical Sciences, University of Milano, Milan, Italy.
  • Mauri A; Center of Functional Genomics and Rare Diseases, Department of Pediatrics, Buzzi Children's Hospital, Milan, Italy.
  • Berardo C; Center of Functional Genomics and Rare Diseases, Department of Pediatrics, Buzzi Children's Hospital, Milan, Italy.
  • Bonaventura E; Department of Biology and Biotechnology "L. Spallanzani" (DBB), University of Pavia, Pavia, Italy.
  • Tonduti D; Pediatric Clinical Research Center "Romeo ed Enrica Invernizzi," Department of Biomedical and Clinical Sciences, University of Milano, Milan, Italy.
  • Carelli S; Center of Functional Genomics and Rare Diseases, Department of Pediatrics, Buzzi Children's Hospital, Milan, Italy.
  • Cereda C; Pediatric Clinical Research Center "Romeo ed Enrica Invernizzi," Department of Biomedical and Clinical Sciences, University of Milano, Milan, Italy.
Wiley Interdiscip Rev RNA ; 15(3): e1854, 2024.
Article en En | MEDLINE | ID: mdl-38831585
ABSTRACT
Leukodystrophies are a class of rare heterogeneous disorders which affect the white matter of the brain, ultimately leading to a disruption in brain development and a damaging effect on cognitive, motor and social-communicative development. These disorders present a great clinical heterogeneity, along with a phenotypic overlap and this could be partially due to contributions from environmental stimuli. It is in this context that there is a great need to investigate what other factors may contribute to both disease insurgence and phenotypical heterogeneity, and novel evidence are raising the attention toward the study of epigenetics and transcription mechanisms that can influence the disease phenotype beyond genetics. Modulation in the epigenetics machinery including histone modifications, DNA methylation and non-coding RNAs dysregulation, could be crucial players in the development of these disorders, and moreover an aberrant RNA maturation process has been linked to leukodystrophies. Here, we provide an overview of these mechanisms hoping to supply a closer step toward the analysis of leukodystrophies not only as genetically determined but also with an added level of complexity where epigenetic dysregulation is of key relevance. This article is categorized under Regulatory RNAs/RNAi/Riboswitches > Regulatory RNA RNA in Disease and Development > RNA in Disease RNA in Disease and Development > RNA in Development.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Epigénesis Genética Límite: Animals / Humans Idioma: En Revista: Wiley Interdiscip Rev RNA Año: 2024 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Epigénesis Genética Límite: Animals / Humans Idioma: En Revista: Wiley Interdiscip Rev RNA Año: 2024 Tipo del documento: Article País de afiliación: Italia